Nils‐Erik Heldin
Impact in
- Molecular Biology top 2%
- TGF-β signaling in diseases
- Cancer-related gene regulation
- Connective Tissue Growth Factor Research
- Kruppel-like factors research
- Renal and related cancers
- Bone Metabolism and Diseases
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 9
- Oncology 14
- Cancer Cells and Metastasis 6
- Cancer-related Molecular Pathways 4
- Co-authors
- Carl‐Henrik HeldinPeter ten DijkeSusumu ItohMozhgan AfrakhteRainer HeuchelMasahiro KawabataTakuya NakayamaJan L. Christian
- Journals
- Thyroid (5 papers)International Journal of Cancer (4 papers)Biochemical and Biophysical Research Communications (4 papers)Endocrinology (2 papers)Journal of Cellular Physiology (2 papers)
- Partner nations
- SwedenUnited StatesNorway
In The Last Decade
Nils‐Erik Heldin
37 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Molecular Biology 2.7k
- Oncology 1.0k
- Cancer Research 423
- Immunology and Allergy 153
- Hepatology 181
Countries citing papers authored by Nils‐Erik Heldin
This map shows the geographic impact of Nils‐Erik Heldin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nils‐Erik Heldin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nils‐Erik Heldin more than expected).
Fields of papers citing papers by Nils‐Erik Heldin
This network shows the impact of papers produced by Nils‐Erik Heldin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nils‐Erik Heldin. The network helps show where Nils‐Erik Heldin may publish in the future.
Co-authors
The 25 scholars most cited alongside Nils‐Erik Heldin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 14 | |
| 2 | 2008 | 17 | |
| 3 | 2007 | 19 | |
| 4 | 2006 | 56 | |
| 5 | 2005 | 44 | |
| 6 | 2005 | 7 | |
| 7 | 2003 | 197 | |
| 8 | 2002 | 44 | |
| 9 | 2001 | 24 | |
| 10 | 2000 | 26 | |
| 11 | 2000 | 112 | |
| 12 | 1999 | 48 | |
| 13 | 1999 | 47 | |
| 14 | 1999 | 34 | |
| 15 | Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling Hit paper breakdown → | 1997 | 1557 |
| 16 | 1995 | 21 | |
| 17 | 1991 | 33 | |
| 18 | 1991 | 55 | |
| 19 | 1991 | 23 | |
| 20 | 1990 | 43 |
About Nils‐Erik Heldin
Nils‐Erik Heldin is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology, Molecular Biology, Hepatology and Toxicology, having authored 37 papers that have together received 3.5k indexed citations. Recurring topics across this work include TGF-β signaling in diseases (14 papers), Thyroid Cancer Diagnosis and Treatment (9 papers), Cancer Cells and Metastasis (6 papers), Cancer-related Molecular Pathways (4 papers), Estrogen and related hormone effects (4 papers), Liver physiology and pathology (3 papers), Renal and related cancers (3 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). The work is most often cited by research in Molecular Biology (2.7k citations), Oncology (1.0k citations), Cancer Research (423 citations), Immunology and Allergy (153 citations) and Hepatology (181 citations). Nils‐Erik Heldin has collaborated with scholars based in Sweden, United States and Norway. Frequent co-authors include Carl‐Henrik Heldin, Peter ten Dijke, Susumu Itoh, Mozhgan Afrakhte, Rainer Heuchel, Masahiro Kawabata, Takuya Nakayama, Jan L. Christian, Atsuhito Nakao and Bengt Westermark. Their work appears in journals such as Thyroid, International Journal of Cancer, Biochemical and Biophysical Research Communications, Endocrinology and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.